col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Association for Cancer Research

214 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Cancer Epidemiology Biomarkers & Prevention 2022―May―04 Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study Joshua W. Bliss, Jessica A. Lavery, Whitney P. Underwood, Su S. Chun, Gina A. Fickera, Catherine P. Lee, et al. (+8)
2 [GO] Cancer Prevention Research 2022―May―03 Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs Goli Samimi, Margaret House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody, et al. (+8)
3 [GO] Cancer Discovery 2022―May―02 Top COVID-19 Prognostic Factors Identified
4 [GO] Cancer Discovery 2022―Apr―04 Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection Lisa H.F. McGary, Santosha A. Vardhana
5 [GO] Blood Cancer Discovery 2022―Mar―09 Patients recently treated for B-lymphoid malignancies show increased risk of severe COVID-19: a CCC19 registry analysis Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, et al. (+54)
6 [GO] Cancer Discovery 2022―Mar―09 The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals. Jean-Eudes Fahrner, Imran Lahmar, Anne-Gaelle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, et al. (+62)
7 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-09: Implications of protocol modifications and treatment delays for breast cancer patient experiences during Covid-19 Tamara Hamlish, Elizabeth L Papautsky
8 [GO] Cancer Research 2022―Mar―08 Abstract P3-01-12: The impact of COVID-19 on diagnosis of recurrent breast cancer Serena Di Cosimo, Catherine Depretto, Rosalba Miceli, Paolo Baili, Silva Ljevar, Milena Sant, et al. (+12)
9 [GO] Cancer Research 2022―Mar―08 Abstract P2-11-08: Impact of COVID-19 on patients undergoing neoadjuvant therapy: A pre/post pandemic analysis and assessment of quality of care delivered Lauren Corke, Omar Hajjaj, Kaylie Willemsma, Stephen Chia, Christine Simmons
10 [GO] Cancer Research 2022―Mar―08 Abstract P2-10-05: The estimated impact of COVID-19 on population breast cancer screening outcomes, and options for risk-based recovery Pietro Procopio, Sabine Deij, Louiza S Velentzis, Amanda Tattam, Lara Petelin, Carolyn Nickson
11 [GO] Cancer Research 2022―Mar―08 Abstract P1-17-07: Consequences of stopping a 4/6 cyclin D-dependent kinase Inhibitor in metastatic breast cancer patients with clinical benefit on endocrine treatment, in the context of the COVID-19 outbreak Sophie Martin, Carole Pflumio, Philippe Trensz, Frederique Schaff-Wendling, Michal Kalish, Cathie Fischbach, et al. (+4)
12 [GO] Cancer Research 2022―Mar―08 Abstract P3-12-37: The impact of the COVID-19 outbreak on breast cancer stage in the Netherlands by screening status Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Carla H van Gils, Marc BI Lobbes, Vivianne CG Tjan-Heijnen, et al. (+4)
13 [GO] Cancer Research 2022―Mar―08 Abstract P3-12-09: Impact of the COVID-19 outbreak on the treatment strategy of Dutch breast cancer patients Anouk H Eijkelboom, Sabine Siesling, Linda de Munck, Desiree HJG van den Bongard, Willemien Menke-van der Houven van Oordt, Pieter J Westenend, et al. (+12)
14 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-06: Predictors of adherence to oral endocrine therapy in racial and ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan, Daniel Moussa, Susan Abughosh, Meghana V Trivedi
15 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-03: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
16 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-15: Examining inequities related to inpatient hospital length of stay for breast cancer patients: A retrospective study during the COVID-19 pandemic Sailaja Kamaraju, Bethany Canales, Tamiah Wright, John Charlson, Aniko Szabo, Thomas Wetzel, et al. (+2)
17 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-01: National claims data analysis of breast cancer diagnosis and treatment before versus during the COVID-19 pandemic Jennifer L Caswell-Jin, Maryam N Shafaee, Lan Xiao, Mina Liu, Natasha Purington, Esther M John, et al. (+2)
18 [GO] Cancer Research 2022―Mar―08 Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, et al. (+6)
19 [GO] Cancer Research 2022―Mar―08 Abstract P3-04-04: Multi-institutional perspective on screening mammography and breast cancer stage at diagnosis during the COVID-19 pandemic Sarah J Stephens, Maxwell R Lloyd, Julian C Hong, Tejas Mehta, Ted A James, Rachel Blitzblau, et al. (+2)
20 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-04: A comprehensive, multidisciplinary approach to breast cancer treatment during the COVID-19 pandemic improves time to treatment Amila Orucevic, Robin Hutson, Robert Heidel, Jillian Lloyd, Garnetta Morin-Ducote, Christine Lauro, et al. (+5)
21 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-12: Assessing the impact of the COVID-19 pandemic on cancer treatment decision-making and care experiences Noura Alsafar, Desiree Hao, Nimira Alimohamed, Sunil Samnani, Sasha Lupichuk
22 [GO] Cancer Research 2022―Mar―08 Abstract P3-09-19: The utility of using genomic testing on needle core biopsies during the COVID-19 pandemic: Molecular characterization, risk stratification, neoadjuvant outcome, and future implications Hani Katerji, Huina Zhang, Xi Wang, Linda Schiffhauer, Ajay Dhakal, Alissa Huston, et al. (+3)
23 [GO] Cancer Research 2022―Mar―08 Abstract P3-03-19: Incidence and time to resolution of axillary adenopathy on mammography after COVID-19 vaccination Kristin Robinson, Santo Maimone, Pooja P Advani, Zhuo Li, Denise Gococo-Benore, Neda Qosja, et al. (+8)
24 [GO] Cancer Research 2022―Mar―08 Abstract P1-01-01: Prospective ultrasonographic surveillance study for incidence and recovery period of COVID-19 vaccination-related axillary lymphadenopathy Kumiko Kida, Hiroko Tsunoda, Risa Kasahara, Chika Tsutsumi, Akiko Numata, Yuri Takehara, et al. (+5)
25 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-17: Declining the COVID-19 vaccination: An evaluation of why some high risk cancer patients decline vaccination Kate I Lathrop, Eva Prieto, Stefany Viveros, Salyna Riggs, Eva Balboa, Juanita Murray, et al. (+2)
26 [GO] Cancer Research 2022―Mar―08 Abstract P2-15-03: Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID-19: A single institution experience Julie Huang, Joshua Feinberg, Bahram Dabiri, Jordan Baum, Meredith Akerman, Anthony Pasquarella, et al. (+4)
27 [GO] Cancer Research 2022―Mar―08 Abstract P2-03-01: Changes in breast cancer presentation during Covid-19: Experience in an Urban Academic Center Amber Azniv Guth, Brian Diskin, Freya Schnabel, Nakisa Pourkey, Deborah Axelrod, Richard Shapiro
28 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, et al. (+4)
29 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-01: Antibody responses after SARS-CoV-2 mRNA vaccination in breast cancer patients Saranya Chumsri, Pooja P. Advani, Tanmayi S Pai, Zhou Li, Marites Acampora, Gina A Reynolds, et al. (+3)
30 [GO] Cancer Research 2022―Mar―08 Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer Cory Bivona, Kevin Li, Priyanka Sharma, Jianghua He, Grace Martin, Andrew K Godwin, et al. (+19)
31 [GO] Cancer Research 2022―Mar―08 Abstract P3-23-02: Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer receiving CDK 4/6 inhibitors Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Alejandro Balazs, Lindsey Mortensen, Elizabeth Niehoff, et al. (+11)
32 [GO] Cancer Research 2022―Mar―08 Abstract P3-11-02: Evaluation of the effects of anticancer treatments in cancer patients undergoing SARS-COV2 vaccination (VAX-on study: Breast cancer subgroup analysis) Agnese Fabbri, Eleonora Marrucci, Fabrizio Nelli, Marco Mazzotta, Angelo Onorato, Primi Francesca, et al. (+7)
33 [GO] Cancer Research 2022―Mar―08 Abstract P4-10-06: Best quality care from a distance (BQual-D): Maintaining high quality care for hormone receptor positive (HR+) metastatic breast cancer (MBC) during the COVID pandemic, description of the program and provider satisfaction Gretchen Kimmick, Smrithi Davakaran, Heather Moore, Cynthia Rose, Pamela Gentry, Michael Willis, et al. (+6)
34 [GO] Cancer Research 2022―Mar―08 Abstract P4-12-13: Psychosocial aspects in relation to clinical status of breast cancer patients after prolonged COVID pandemic in south India: A observational survey study Chandralekha Krishnan
35 [GO] Cancer Research 2022―Mar―08 Abstract P5-14-04: Changes in management of TNBC during the COVID19 pandemic of 2020 Dave Smart, Wendy L Allen, Raymond H Henderson, Susanne Munksted, Peter Riccelli
36 [GO] Cancer Research 2022―Mar―08 Abstract P3-17-06: Telephone triaging during the 1st wave of the COVID 19 Pandemic: Outcomes and proposed pathway for managing patients referred for breast pain Urvashi Jain, Robyn Coombe, Georgina Bitsakou, Ashutosh Kothari
37 [GO] Clinical Cancer Research 2022―Feb―09 AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care Patrick A. Williams, Sayyed Kaleem Zaidi, Rajarshi Sengupta
38 [GO] Cancer Immunology Research 2022―Jan―24 Immune-guided therapy of COVID-19 Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, et al. (+2)
39 [GO] Cancer Discovery 2021―Dec―22 Pandemic Provides Rapid Test of Telehealth
40 [GO] Cancer Discovery 2021―Dec―10 Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer Arielle Elkrief, Julie T Wu, Chinmay Jani, Kyle T Enriquez, Michael Glover, Mansi R Shah, et al. (+13)
41 [GO] Cancer Discovery 2021―Dec―09 Navigating Cancer Care in the COVID-19 Era
42 [GO] Cancer Research 2021―Nov―10 Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients Jane C Figueiredo, Noah M Merin, Omid Hamid, So Yung Choi, Tucker Lemos, Wendy Cozen, et al. (+27)
43 [GO] Cancer Discovery 2021―Nov―09 Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies Christina Y. Lee, Monika K Shah, David Hoyos, Alexander Solovyov, Melanie Douglas, Ying Taur, et al. (+5)
44 [GO] Cancer Discovery 2021―Oct―06 COVID-19 Use Causes Tocilizumab Shortage
45 [GO] Cancer Prevention Research 2021―Oct―04 Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies Ana Ribeiro, Flávia Corrêa, Arn Migowski, Aline Leal, Sandro Martins, Tainá Raiol, et al. (+8)
46 [GO] Clinical Cancer Research 2021―Sep―28 Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution. Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Vittoria Barberi, Maria Teresa Maccallini, Ludovica Gariazzo, et al. (+18)
47 [GO] Blood Cancer Discovery 2021―Sep―15 How to provide the needed protection from COVID-19 to patients with hematologic malignancies Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, Faith E Davies, Steven D. Gore, Ronald Levy, Lee M Greenberger
48 [GO] Blood Cancer Discovery 2021―Sep―13 Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies David J Chung, Gunjan L. Shah, Sean M. Devlin, Lakshmi V Ramanathan, Sital Doddi, Melissa S Pessin, et al. (+18)
49 [GO] Blood Cancer Discovery 2021―Sep―13 Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T Cell Therapy Roni Tamari, Ioannis Politikos, David A Knorr, Santosha A Vardhana, Jennifer C Young, LeeAnn T Marcello, et al. (+12)
50 [GO] Cancer Discovery 2021―Sep―01 Impaired CD4 T-cell Response to SARS-CoV-2: Rationale for PD-1 Blockade in Patients with Cancer and COVID-19? Bérengère Salomé, Amir Horowitz
51 [GO] Cancer Discovery 2021―Jul―21 Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective Keith T. Flaherty, James H. Doroshow, Susan Galbraith, Antoni Ribas, Paul G. Kluetz, Richard Pazdur, Marc R. Theoret
52 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―16 Characteristics and outcomes of over 300,000 COVID-19 individuals with history of cancer in the United States and Spain Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G Sena, Sergio Fernandez-Bertolin, Maria Aragon, et al. (+47)
53 [GO] Cancer Discovery 2021―Jul―16 Patients with Solid Tumors Seroconvert after SARS-CoV-2 mRNA Vaccine
54 [GO] Cancer Discovery 2021―Jul―07 COVID-19 Vaccines Complicate Breast Screening
55 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―07 Excess mortality in a nationwide cohort of cancer patients during the initial phase of the COVID 19 pandemic in Belgium Geert Silversmit, Freija Verdoodt, Nancy Van Damme, Harlinde De Schutter, Liesbet Van Eycken
56 [GO] Cancer Research 2021―Jul―01 Abstract 703: An inflammatory leptomeningeal signature in cancer patients with neurologic manifestations of COVID-19 Jessica A. Wilcox, Jan Remsik, N. Esther Babady, Tracy A. McMillen, Behroze A. Vachha, Neil A. Halpern, et al. (+6)
57 [GO] Cancer Research 2021―Jul―01 Abstract 710: Androgen-deprivation therapy boosts MX1 expression, a silent effector against COVID-19 Juan Antonio Bizzotto, Pablo Sanchis, Sofia Lage-Vickers, Rosario Lavignolle, Agustina Sabater, Mercedes Abbate, et al. (+9)
58 [GO] Cancer Research 2021―Jul―01 Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19 Daniella Vaskovich-Koubi, Ron Kleiner, Yulia Liubomirski, Eilam Yeini, Galia Tiram, Sabina Pozzi, et al. (+3)
59 [GO] Cancer Research 2021―Jul―01 Abstract 704: Sex and age differences in telomere length and susceptibility to COVID-19 Manar Ahmed Kamal, Kareem Reda Alamiry, Mahmoud Zaki
60 [GO] Cancer Research 2021―Jul―01 Abstract 711: Repurposing 2nd generation androgen receptor antagonist Proxalutamide to treat COVID-19 Liandong Ma, Youzhi Tong, Qiang Guo, Yifeng Zhou, Qianxiang Zhou, Honghua Yan
61 [GO] Cancer Research 2021―Jul―01 Abstract 709: Estrogen and androgen receptor inhibitors: Unexpected allies in the fight against COVID-19 Sara Bravaccini, Eugenio Fonzi, Michela Tebaldi, Davide Angeli, Giovanni Martinelli, Fabio Nicolini, et al. (+2)
62 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 74: Stakeholder Selected Strategies to Improve Breast Cancer Care in East Africa: Preliminary Implementation Outcomes and Impact Of COVID-19 Anne Rositch, Christina Chao, Matogoro Kirahi, Nestory Masalu, Lucas Faustine, Leonard Washington Amango
63 [GO] Cancer Research 2021―Jul―01 Abstract 700: CellSig: A data-driven model of cytokine activity identifies therapeutic targets for severe COVID-19 and cancer immunotherapy-induced colitis Peng Jiang, Yu Zhang, Beibei Ru, Eytan Ruppin, Kai Wucherpfennig
64 [GO] Cancer Research 2021―Jul―01 Abstract 722: The hallmark of COVID-19 cancer disparities: Cellular sequelae Eva McGhee, Mengtao LI, Yi-Ling Lin, Nefertari Carr, Chinelo Njubigbo, Rohun Sadeghi, et al. (+6)
65 [GO] Cancer Research 2021―Jul―01 Abstract LB076: Association between regional COVID-19 hospitalizations and treatment delays amongst confirmed cancer patients in England, UK Louis Fox, Ajay Aggarwal, Richard Sullivan, Kate Haire, Arnie Purushotham, James Spicer, et al. (+4)
66 [GO] Cancer Research 2021―Jul―01 Abstract LB074: Chymostatin, a cathepsin L inhibitor, inhibits lung cancer cell proliferation and COVID-19 Mpro in vitro Nagendra Sastry Yarla, Gopal Pathuri, Simon Terzyan, Yuting Zhang, Anil Singh, Marcus T. Scotti, et al. (+2)
67 [GO] Cancer Research 2021―Jul―01 Abstract CT201: Early report of a phase I/II study of human placental hematopoietic stem cell derived natural killer cells (CYNK-001) for the treatment of adults with COVID-19 (NCT04365101) Corey Casper, Leonid Groysman, Vinay Malhotra, Eric Whitman, Stacy Herb, Erica Rave, et al. (+17)
68 [GO] Cancer Research 2021―Jul―01 Abstract LB073: The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic Md Mohiuddin, Hideharu Kimura, Takashi Sone, Satoshi Watanabe, Hiroki Matsuoka, Keigo Saeki, et al. (+3)
69 [GO] Cancer Research 2021―Jul―01 Abstract 716: Telehealth use among multiple myeloma patients during the COVID-19 pandemic Nathan W. Sweeney, Scott R. Goldsmith, Jennifer M. Ahlstrom
70 [GO] Cancer Research 2021―Jul―01 Abstract 719: The emergence of the COVID-19 pandemic and its impact on a novel cancer care delivery model at Federally Qualified Health Centers Nicolas Francone, Will Dunne, Jonathan Alhalel, Sankirtana Danner, Nihmotallahi Adebayo, T Madorsky, et al. (+6)
71 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 11: Neglected Elements of Cancer Control During The COVID-19 Pandemic in Africa: Call for Action from 2019-2020 African Cancer Research and Control ECHO Programme Annet Nakaganda, Nwamaka Lasebikan, Elise M. Garton, Benda Kithaka, Mishka K. Cira
72 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 31: Impact of the COVID-19 Pandemic on Cancer Registry Operations in the Caribbean Sarah Quesnel-Crooks, Rachel Hanisch, Isabelle Soerjomataram, Brenda Edwards, Arica White, Betsy Kohler, et al. (+3)
73 [GO] Cancer Research 2021―Jul―01 Abstract 717: Rapid transformation of TTFields care-delivery during COVID-19 pandemic to optimize treatment of patients with glioblastoma (GBM) Peggy M. Frongillo, Melissa Shackelford, Lindsay Rain
74 [GO] Cancer Research 2021―Jul―01 Abstract 721: Early death in acute lymphoblastic leukemia during COVID-19 pandemic: A single institution cohort study Daniel J. Enriquez-Vera, Ali Al-kassab-Cordova, Lizbeth Lachira-Yparraguirre, Gustavo Sandival-Ampuero, Bryan Valcarcel, Cesar Samanez, et al. (+5)
75 [GO] Cancer Research 2021―Jul―01 Abstract 1162: Monitoring COVID-19 RNA methyltransferases activities for developing therapeutic drugs Said A. Goueli, Kevin Hsiao
76 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 65: Early Assessment of the Pandemic Effects on Cancer Screening Services: The International Cancer Screening Network COVID-19 Survey Douglas M. Puricelli Perin, K. Miriam Elfström, Mireille J. M. Broeders
77 [GO] Cancer Research 2021―Jul―01 Abstract 715: Flow cytometry analysis of immune response to COVID-19 vaccine candidates using an in vitro stimulation model Xiaoshan Shi, Scott J. Bornheimer, Suraj Saksena, Stephanie Widmann, Aaron Tyznik
78 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Jul―01 Abstract 18: Cancer Control Assessments in Low- and Middle-Income Countries during COVID-19: The IAEA-IARC-WHO imPACT Review Hybrid Modality Marianna Nobile, Kendall Siewert, Maria Tena Perpina, Yuliya Lyamzina
79 [GO] Cancer Research 2021―Jul―01 Abstract 712: Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study Amaresh Mishra, Yamini Pathak, Gourav Choudhir, Anuj Kumar, Surabhi Kirti Mishra, Vishwas Tripathi
80 [GO] Cancer Research 2021―Jul―01 Abstract 706: Rapid detection of SARS-CoV-2 antigen and antibody seroconversion in clinical specimens using a novel Surface Programmable Activation Receptor (SPAR) modified T cell diagnostic method Aaron K. LeFebvre, Melissa Frenchmeyer, Kyle M. McQuaid, MRussell Williams, Charles M. McBrairty, Joseph D. Kittle
81 [GO] Cancer Research 2021―Jul―01 Abstract 713: Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs Rao V. Papineni, Amitava Adhikary, Ritesh Tandon, Dipanwita Mitra
82 [GO] Cancer Research 2021―Jul―01 Abstract 707: Detection of SARS-CoV-2 co-infections with seasonal respiratory viruses using a multiplexed amplicon NGS panel Lucie S. Lee, Rounak Feigelman, David Debruyne, Julia Spencer, Chenyu Li, Zhitong Liu, Guoying Liu
83 [GO] Cancer Research 2021―Jul―01 Abstract 701: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
84 [GO] Cancer Research 2021―Jul―01 Abstract 705: SARS-CoV-2 infection of the human heart governs intracardiac innate immune response Anthony W. Ashton, Liang Zhang, Yan Liang, Prajan Divakar, Carolos Cordon-Cardo, Richard G. Pestell
85 [GO] Cancer Research 2021―Jul―01 Abstract LB075: Development of SARS-CoV-2 neutralizing protein by ACE2 receptor engineering for severe infection and patients with underlying diseases Byoung S. Kwon, Seunghyun Lee, Jin-Kyung Choi, Bora Hwang, Sun-Woo Im, Yun-Sook Lim, et al. (+3)
86 [GO] Cancer Research 2021―Jul―01 Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus Zhiqiang Qin, Jungang Chen, Lu Dai, Lindsey Barrett, Steven Post
87 [GO] Cancer Research 2021―Jul―01 Abstract 702: Single-cell expression landscape of SARS-CoV-2 receptor ACE2 and host proteases in human lung adenocarcinoma Guangchun Han, Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick Brennan, Kyle Chang, et al. (+25)
88 [GO] Clinical Cancer Research 2021―Jun―09 A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes David A. Potter, Alexandra Thomas, Hope S. Rugo
89 [GO] Cancer Discovery 2021―Jun―04 COVID-19 Reshapes Cancer Clinical Research
90 [GO] Cancer Discovery 2021―May―19 Preexisting and post-COVID-19 immune responses to SARS-CoV-2 in cancer patients Tatjana Bilich, Malte Roerden, Yacine Maringer, Annika Nelde, Jonas S Heitmann, Marissa L Dubbelaar, et al. (+16)
91 [GO] Cancer Discovery 2021―May―14 Blood Cancers Diminish Response to COVID-19 Vaccine
92 [GO] Cancer Prevention Research 2021―Apr―28 Q&A: Ned Sharpless on COVID-19 and Cancer Prevention
93 [GO] Cancer Discovery 2021―Apr―12 Repurposing of anticancer drugs expands possibilities for antiviral and anti-inflammatory discovery in COVID-19 Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, Antoni Ribas, Jean-Charles Soria
94 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Voices of Community Organizations: How Cancer Centers Can Support Communities in the Face of COVID-19 JD Austin, E Lee, RC Shelton, G Hillyer, K Schmitt, P Tehranifar
95 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Financial and Employment Impacts of Cancer and COVID-19 Among African American Cancer Survivors TA Hastert, JJ Ruterbusch, AL Best, FWK Harper, H Thompson, JL Beebe-Dimmer, AG Schwartz
96 [GO] Cancer Discovery 2021―Apr―02 Treatment Decisions for Patients with Cancer during the COVID-19 Pandemic Chris Labaki, Solange Peters, Toni K. Choueiri
97 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Impact of COVID-19 Pandemic on Healthcare Delivery, Behavioral Outcomes, and Financial Stress in 1,253 Individuals with Cancer at Huntsman Cancer Institute (HCI) AR Peoples, C Himbert, CA Hathaway, AC Kirchhoff, J Ose, T Lin, et al. (+9)
98 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Apr―02 Improving Survey Response Rates Among Patients at a Cancer Center During a Global Pandemic CA Hathaway, EM Siegel, B Gonzalez, SS Tworoger
99 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P30: Long-term outcomes of cancer patients infected with COVID-19 Justin Shaya, Angelo Cabal, Pedram Razavi, Rana R. McKay
100 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P22: A high-throughput anti-SARS-CoV-2 IgG testing platform for COVID-19 Jinwei Du, Eric Chu, Dayu Zhang, Chuanyi M. Lu, Aiguo Zhang, Michael Sha
101 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 Giulia Monticone, Alistair Ramsay, Lucio Miele
102 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P12: Colorectal cancer screening in Appalachian Kentucky primary care clinics during COVID-19 Aaron J. Kruse-Diehr, Mark Cromo, Melinda Rogers, Angela Carman, Bin Huang, David Gross, et al. (+3)
103 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P41: Mental health and coping during COVID-19 among cancer patients and survivors Jeanine P.D. Guidry, Carrie A. Miller, Bernard F. Fuemmeler
104 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-02: Factors associated with developing COVID-19 among cancer patients in New York City Monica F. Chen, Monica T. Coronel, Samuel Pan, Arreum Kim, Jessica Hawley, Gary Schwartz, Katherine Crew
105 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-04: Asymptomatic detection of COVID-19 among cancer patients receiving infusional anti-cancer therapy Justin A. Shaya, Angelo Cabal, Francesca Torriani, Joseph Califano, Scott Lippman, Assuntina Sacco, Rana R. McKay
106 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy Sylvain Lamure, Remy Dulery, Marc Delord, Roberta Di Blasi, Adrien Chauchet, Thomas Hueso, et al. (+19)
107 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P24: Evidenced-based natural therapies and immune-enhancing strategies to control, prevent, and treat co-morbidities COVID-19 and cancer Padma P. T. Uppala, Sherri Isaak, Brian Wong, Kimberly Ferreira, Carlos Garberoglio, John Kelly
108 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-02: Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study Sheena Bhalla, Ziad Bakouny, Andrew L. Schmidt, John A. Steinharter, Douglas A. Tremblay, Mark M. Awad, et al. (+24)
109 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P25: Prostate cancer and COVID-19 outcomes: Results from the Cleveland Clinic registry of COVID-19 and cancer patients Scott J. Dawsey, Nathan A. Pennell, Christopher Lemmon, Amanda Nizam, Wei Wei, Timothy D. Gilligan, et al. (+2)
110 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-04: Using CXR-Net to detect COVID-19 and non-COVID-19 patients Benjamen Huber, Abdulah Haikal, Domenico Gatti, Hamid Soltanian-Zadeh
111 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-03: Adolescent and young adult cancer patient and survivor employment changes during COVID-19 are associated with financial toxicity Austin Waters, Heydon Kaddas, Karely Mann, Perla L. Vaca Lopez, Echo L. Warner, Joemy Ramsay, et al. (+9)
112 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P23: Detection of humoral and cellular responses to SARS-CoV-2 in COVID-19 convalescents Anna Baranska, Marc Schuster, Marek Wieczorek, Sebastian Flade, Lennart Wessels, Burhan Karaca, et al. (+3)
113 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-03: Clinical and demographic characteristics associated with shorter time to COVID-19 death Maria J. Monroy-Iglesias, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Sophie Papa, et al. (+35)
114 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-04: COVID-19 disease in patients with lung cancer in Spain: GRAVID Lung Cancer Patients Disease (GRAVID study) Jose Maria Mazarico Gallego, Antonio Calles, Monica Antoñanzas, Cristina Pangua, Xabier Mielgo Rubio, Ernest Nadal, et al. (+16)
115 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P06: Anticancer agent 3-deazauridine has the potential to be effective against COVID-19 due to its inhibition of replication of RNA viruses Richard Momparler
116 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-06: Social Determinants of Health (SDOH) barriers as predictors of intent to vaccinate for COVID-19 in a vulnerable population Beth A. Jones, William Eger, Sakinah Suttiratana, Roy Herbst, Eiman Ibrahim, Hannah Behringer, Rachel A. Clare
117 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-05: Prevalence of COVID-19 in asymptomatic cancer patients on active systemic treatment in a public Brazilian hospital: The impact of socioeconomic status Luiza Fadul, Barbara Benetton, Larissa Furlan, Marina Topanotti, Marcia Lanza, Mauricio Nogueira, et al. (+2)
118 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P11: The elevated level of the main markers of neutrophil extracellular traps in metastatic colorectal cancer plasma highlights the enhanced risk of severe forms of COVID-19 in cancer patients Alain R. Thierry, Brice Pastor, Jean-Daniel Abraham, Ekaterina Pisareva, Thibault Mazard
119 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P33: Disparities in breast cancer screening and the impact of COVID-19 in Houston, Texas Maryam Nemati Shafaee, Luke Gilman, Abiodun Oluyomi, Melissa Bondy, Tamara Ortiz-Perez, Chris Amos, Mothaffar Rimawi
120 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-03: Outcomes of COVID-19 in patients with cancer: Results of a prospective observational comparison of routine screening strategy versus testing based on clinical suspicion Zhuoer Xie, Antoine N. Saliba, Jithma Abeykoon, Umair Majeed, Daniel Almquist, Julia Wiedmeier-Nutor, et al. (+20)
121 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S11-03: The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy’s Cancer Center Rushan Sylva, Beth Russell, Charlotte Moss, Gincy George, Kieran Palmer, Vallari Shah, et al. (+14)
122 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P43: Clinical characteristics of COVID-19 infected cancer patients: A retrospective study in Royal Wolverhampton NHS Trust, United Kingdom Menna M. Fouda, Ankit Jain
123 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P42: Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID-19 infection Jian He, Mei Meng, Yiyang Zhao
124 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P28: COVID-19 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT): The Guy’s Cancer Centre experience Lucy Flanders, Beth Russell, Charlotte Moss, Kieran Palmer, Rushan Sylva, Gincy George, et al. (+14)
125 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-02: Comprehensive meta-analysis of COVID-19 mortality rates for 22 cancer subtypes from the Reboot: COVID-Cancer Project, an interactive resource with aggregated data from 21,839 cancer patients Emily-Claire Duffy, Kelly Fan, Shailesh Advani, Chris Bailey, James R.M. Black, Ellie Strauss, et al. (+9)
126 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S12-01: Quantifying the impact of COVID-19 on cancer care: Pathology volume change in SEER cancer registries Todd Golden, Linda Coyle, Jennifer Stevens, Serban Negoita
127 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P05: EpistoNet: An ensemble of deep convolutional neural networks using mixture of discriminative experts for detecting COVID-19 on chest X-ray images Seyed Ziae Mousavi Mojab, Seyedmohammad Shams, Farshad Fotouhi, Hamid Soltanian-Zadeh
128 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P44: Factors affecting COVID-19 outcomes in cancer patients from Guy’s Cancer Center and King's College Hospital Kieran Palmer, Rushan Sylva, Beth Russell, Charlotte Moss, Vallari Shah, Thinzar Ko Ko, et al. (+22)
129 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S06-04: Telehealth experiences of adolescent and young adult cancer patients and survivors during the COVID-19 pandemic Karely Mann, Austin R. Waters, Perla L. Vaca Lopez, Echo L. Warner, Judy Ou, Heydon Kaddas, et al. (+9)
130 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P40: PTSD and levels of general anxiety in Italian oncological patients during the COVID-19 pandemic Mariam Chichua, Eleonora Brivio, Serena Oliveri, Paolo Guiddi, Gabriella Pravettoni
131 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-04: Drive By Flu-FIT: A novel way to mitigate the decrease in colorectal cancer screening during the COVID-19 pandemic Armenta Washington, Leroy Miles, Claudia Melendez, Brenda Bryant, Alexander Auchus, Michael Goldberg, et al. (+5)
132 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-04: Disparities in food insecurity among cancer survivors during the U.S. COVID-19 pandemic Marlene Camacho-Rivera, Jessica Y. Islam, Denise C. Vidot
133 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic Md Mohiuddin, Kazuo Kasahara
134 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S04-02: Effects of demographic and behavioral factors on social isolation in a cancer center population during COVID-19 pandemic Cassandra A. Hathaway, Brian D. Gonzalez, Amanda Bloomer, Erin M. Siegel, Cornelia M. Ulrich, Anita R. Peoples, et al. (+2)
135 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P17: Effect of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic Vivek U. Nimgaonkar, Abigail T. Berman, Peter Gabriel, John Kucharczuk, Lawrence N. Shulman, Charu Aggarwal, Melina E. Marmarelis
136 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-02: The impact of resuming the breast cancer screening program in the Netherlands on breast cancer incidence and stage after its discontinuation due to the COVID-19 pandemic Anouk H. Eijkelboom, Linda de Munck, Marc B.I. Lobbes, Jelle Wesseling, Carla H. van Gils, Pieter J. Westenend, et al. (+5)
137 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P36: Virtual cancer care in a tertiary care academic centre in Ireland during the COVID-19 pandemic - An analysis of physician and patient opinion Mary N. O'Reilly, Mark Doherty
138 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S09-03: Real world data analysis of patients with genitourinary cancers receiving systemic anticancer treatment during the COVID-19 pandemic at Guy's Cancer Centre: A single centre retrospective study in the UK Christina Karampera, Beth Russell, Charlotte Moss, Rushan Sylva, Kieran Palmer, Elias Pintus, et al. (+6)
139 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P19: Systemic anticancer treatment changes at the start of the COVID-19 pandemic in a large Australian metropolitan health service Elizabeth Liow, Cameron McLaren, Samuel Tipping-Smith, Sarah Latham, Jun Beng Kong, Marissa Lam, et al. (+4)
140 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P15: Treatment (TX) of advanced melanoma during the Coronavirus Disease 2019 (COVID-19) pandemic in Kaiser Permanente Northern California (KPNC) Juraj Kavecansky, Nina Shah, Angeles Price, Frank Hsieh, Alice Kengla, Belinda Ark, et al. (+12)
141 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S02-03: The impact of the COVID-19 pandemic on Barrett’s esophagus and esophago-gastric cancer Richard C. Turkington, Anita Lavery, David Donnelly, Anna T. Gavin, Damian T. McManus, Victoria Cairnduff, et al. (+4)
142 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P45: A global snapshot of the impact of the COVID-19 pandemic on cancer research: Report from a Global Cancer and COVID-19 Task Force Louis Fox, Verna Vanderpuye, Richard Sullivan, Mieke Van Hemelrijck, Deborah Mukherji
143 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S04-03: Impact of the COVID-19 pandemic on social and health behaviors among rural and urban cancer patients at Huntsman Cancer Institute (HCI) Bailee Daniels, Caroline Himbert, Cassandra A. Hathway, Tengda Lin, Karen Salas, Anjelica Ashworth, et al. (+22)
144 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P32: Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: A population-based study Ashleigh C. Hamilton, David W. Donnelly, Maurice B. Loughrey, Richard C. Turkington, Colin Fox, Deirdre Fitzpatrick, et al. (+3)
145 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S10-02: Financial hardship and mental health among cancer survivors during the COVID-19 pandemic: An analysis of the U.S. COVID Impact Survey Jessica Y. Islam, Denise C. Vidot, Marlene Camacho-Rivera
146 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P02: Predicting mortality in SARS-CoV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network Fahad S. Ahmed, Maleeha Naseem, Hajra Arshad, Syeda Amrah Hashmi, Furqan Irfan
147 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P26: Re-analyzing randomized trials with incorporation of COVID-19 risk associated with cancer therapy Shervin Tabrizi, Lorenzo Trippa, Daniel Cagney, Ayal A. Aizer, Shyam Tanguturi, Steffen Ventz, et al. (+8)
148 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P04: Effects of COVID-19 treatments on cancer: A machine learning approach to synthesize clinical evidence at scale Allison Britt, Emily Yang, Devon Crittenden, Thomas Bhangdia, Ben Nye, Emily-Claire Duffy, et al. (+15)
149 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S05-02: Plant viral nanoparticle-based adjuvants for cancer immunotherapy and COVID-19 vaccines Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, P. Jack Hoopes, Sourabh Shukla, Oscar A. Ortega-Rivera, et al. (+2)
150 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P38: An examination of COVID-19-related preventive behaviors by cancer status Carrie A. Miller, Jeanine P.D. Guidry, Bernard F. Fuemmeler
151 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P34: Health care disparities and outcomes of cancer patients with COVID-19: A pooled analysis of two Brazilian tertiary centers Marina Topanotti, Larissa L. Furlan, Catarina Marchon, Pedro Amaral, Barbara C. Beneton, Luiza A. Fadul, et al. (+5)
152 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P18: Radical cancer treatment is safe during COVID-19: The experience of a large London-based Comprehensive Cancer Centre Beth Russell, Victoria Harris, Harvey Dickinson, Charlotte Moss, Graham Roberts, Kate Haire, et al. (+15)
153 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P20: Continuity of oncology clinical trials during the Coronavirus Disease-2019 pandemic in Korea Hee Kyung Ahn, Soohyeon Lee, Seon-A Jang, Ji-Yeon Kim, Jin Seok Ahn, Yeon Hee Park
154 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-04: Spatial profiling of lung SARS-CoV-2 and influenza virus infection identifies virus specific host responses and gene signatures Arutha Kulasinghe
155 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P21: Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test Qing Sun, Jonathan Li, Hui Ren, Larry Pastor, Yulia Loginova, Joseph Wong, et al. (+4)
156 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-02: Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study Lewis Au, Annika Fendler, Laura Amanda Boos, Fiona Byrnes, Scott Shepherd, Emma Nicholson, et al. (+9)
157 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S03-03: Cancer patients display diminished viral RNA clearance and altered T cell responses during SARS-CoV-2 infection Michael Chiorazzi, Erin Silva, Kristina Brower, Patrick Wong, Carolina Lucas, Jon Klein, et al. (+25)
158 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S01-03: The acute phase response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection as quantified by the OnCovid Inflammatory Score Gino M. Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, et al. (+44)
159 [GO] Clinical Cancer Research 2021―Mar―12 Abstract S01-02: Assessing vulnerability of patients with lung cancer to SARS-CoV-2 infection based on serological antibody analyses Amy C. Moore, Paul A Bunn, Beatriz Fontoura, Adolfo García-Sastre, Jorge Gomez, Florian Krammer, et al. (+6)
160 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P35: Targeting vimentin impacts multiple cellular processes, blocks the spike protein-ACE2-mediated pseudoviral infection in vitro and reduces the symptom and lung injury in aged mice with mouse-adapted SARS-CoV-2 infection in vivo Zhizhen Li, Jianping Wu, Baoshi Yuan, Kenneth Dinnon, Lian Mo, Fei Zhou, et al. (+6)
161 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study Weijing Sun, Andrew K. Godwin, Kathan Mehta, Natalie Streeter, Elizabeth Wulff-Burchfield, Anup Kasi, et al. (+8)
162 [GO] Clinical Cancer Research 2021―Mar―12 Abstract P29: Pre-COVID-19 pandemic vs. post-COVID-19 pandemic: Sustained participation of minorities in research in a CAP accredited biorepository in UC San Diego, California Sharmeela A. Kaushal, David Anjakos, Mason A. Kyle, Diana Cortez-Moreno, Alfredo A. Molinolo
163 [GO] Clinical Cancer Research 2021―Mar―01 Vascular normalization to improve treatment of COVID-19: Lessons from treatment of cancer Lance L Munn, Triantafyllos Stylianopoulos, Natalie K Jain, C Corey Hardin, Melin J Khandekar, Rakesh K. Jain
164 [GO] Cancer Discovery 2021―Feb―26 COVID-19 Prolonged in Patients with Cancer
165 [GO] Cancer Prevention Research 2021―Feb―24 COVID-19 disruptions to endoscopic surveillance in Lynch syndrome Danielle B McKenna, Christina M Dudzik, Shria Kumar, Nadim Mahmud, Bryson W Katona
166 [GO] Cancer Epidemiology Biomarkers & Prevention 2021―Feb―05 Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling? Anita W.W. Lim
167 [GO] Clinical Cancer Research 2021―Feb―04 How did we get a COVID-19 vaccine in less than one year? E. John Wherry, Elizabeth M. Jaffee, Nicholas Warren, Gypsyamber D'Souza, Antoni Ribas
168 [GO] Cancer Discovery 2021―Feb―02 Correction: Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers
169 [GO] Cancer Immunology Research 2021―Jan―15 At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer Antoni Ribas, Marina Chiara Garassino
170 [GO] Blood Cancer Discovery 2021―Jan―13 Cancer and COVID-19: On the Quest for Effective Vaccines Marwan Kwok, Edward F. Fritsch, Catherine J. Wu
171 [GO] Cancer Discovery 2020―Dec―30 Patients with Cancer Seroconvert Typically After SARS-CoV-2 Infection
172 [GO] Cancer Research 2020―Dec―22 Is COVID-19 - induced platelet activation a cause of concern for cancer patients? Lenard M. Lichtenberger, K. Vinod Vijayan
173 [GO] Cancer Discovery 2020―Dec―22 Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited Antoni Ribas, Rajarshi Sengupta, Trevan Locke, Sayyed Kaleem Zaidi, Katie M Campbell, John M. Carethers, et al. (+4)
174 [GO] Cancer Discovery 2020―Dec―22 As Pandemic Continues, Screening Concerns Grow
175 [GO] Molecular Cancer Research 2020―Dec―16 Relevance of the Bruton Tyrosine Kinase (BTK) as a target for COVID-19 therapy Miran Rada, Zahraa Qusairy, Marta Massip-Salcedo, Salvador Macip
176 [GO] Cancer Discovery 2020―Dec―11 Survival Factors ID'd for Patients with Blood Cancer + COVID-19
177 [GO] Blood Cancer Discovery 2020―Nov―04 Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers Malin Hultcrantz, Joshua Richter, Cara A. Rosenbaum, Dhwani Patel, Eric L. Smith, Neha Korde, et al. (+24)
178 [GO] Blood Cancer Discovery 2020―Nov―02 Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19 Madhav V. Dhodapkar, Kavita M. Dhodapkar, Rafi Ahmed
179 [GO] Clinical Cancer Research 2020―Oct―13 Similarities in Risk for COVID-19 and Cancer Disparities Lisa Newman, Robert A Winn, John M. Carethers
180 [GO] Blood Cancer Discovery 2020―Oct―13 Don't Compromise Myeloma Care Due to COVID-19 Pandemic! Nikhil C. Munshi, Kenneth C. Anderson
181 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―Sep―25 Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey Jessica Y Islam, Marlene Camacho-Rivera, Denise C. Vidot
182 [GO] Cancer Prevention Research 2020―Sep―21 COVID-19, Cancer Care and Prevention Raymond N. DuBois
183 [GO] Cancer Discovery 2020―Sep―18 Repurposing Cancer Drugs for COVID-19
184 [GO] Cancer Prevention Research 2020―Sep―17 Disparities in Cancer Prevention in the COVID-19 Era John M. Carethers, Rajarshi Sengupta, Rea Blakey, Antoni Ribas, Gypsyamber D'Souza
185 [GO] Cancer Discovery 2020―Sep―16 Q&A: Solange Peters on COVID-19, Cancer Intersection; Immunotherapy Biomarkers
186 [GO] Cancer Discovery 2020―Sep―01 COVID-19 Challenges Status Quo for Cancer Care
187 [GO] Cancer Discovery 2020―Aug―19 ICI Impact on COVID-19 Severity Modest at Best
188 [GO] Clinical Cancer Research 2020―Aug―18 The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C Tan, et al. (+3)
189 [GO] Blood Cancer Discovery 2020―Jul―31 COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers Malin Hultcrantz, Joshua Richter, Cara A Rosenbaum, Dhwani Patel, Eric L Smith, Neha Korde, et al. (+24)
190 [GO] Cancer Discovery 2020―Jul―31 Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. David J Pinato, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher CT Sng, Ramon Salazar, et al. (+58)
191 [GO] Cancer Discovery 2020―Jul―22 Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M. Kuderer, Chih-Yuan Hsu, et al. (+39)
192 [GO] Cancer Discovery 2020―Jul―15 Cancer Research: The lessons to learn from COVID-19 Chris Bailey, James R M Black, Charles Swanton
193 [GO] Clinical Cancer Research 2020―Jul―02 COVID-19 testing in cancer patients: Does one size fit all? Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, et al. (+3)
194 [GO] Clinical Cancer Research 2020―Jun―15 Immune-Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era Michele Maio, Omid Hamid, James Larkin, Alessia Covre, Maresa Altomonte, Luana Calabrò, et al. (+6)
195 [GO] Cancer Discovery 2020―Jun―08 COVID-19 Delays Cancer Screenings
196 [GO] Clinical Cancer Research 2020―Jun―05 The World of Clinical Trial Development Post-Covid-19: Lessons Learned from a Global Pandemic. Fatima Karzai, Ravi A. Madan, William Dahut
197 [GO] Cancer Discovery 2020―May―29 Registries Offer Insights on COVID-19-Cancer Connection
198 [GO] Cancer Discovery 2020―May―22 The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2 Beril Tutuncuoglu, Merve Cakir, Jyoti Batra, Mehdi Bouhaddou, Manon Eckhardt, David E Gordon, Nevan J Krogan
199 [GO] Cancer Discovery 2020―May―13 The Era of COVID-19 and the Rise of Science Collectivism in Cancer Research Tobias Janowitz, David A. Tuveson
200 [GO] Cancer Discovery 2020―May―12 Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers Jia Luo, Hira Rizvi, Jacklynn V Egger, Isabel R Preeshagul, Jedd D. Wolchok, Matthew D. Hellmann
201 [GO] Cancer Discovery 2020―May―05 Cytokine Storm Drugs Move from CAR T to COVID-19
202 [GO] Cancer Epidemiology Biomarkers & Prevention 2020―May―05 The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action Andrew T. Chan, David A. Drew, Long H. Nguyen, Amit D. Joshi, Wenjie Ma, Chuan-Guo Guo, et al. (+54)
203 [GO] Cancer Discovery 2020―May―01 Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Vikas Mehta, Sanjay Goel, Rafi Kabarriti, Daniel Cole, Mendel Goldfinger, Ana Acuna-Villaorduna, et al. (+13)
204 [GO] Cancer Discovery 2020―Apr―28 Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak Mengyuan Dai, Dianbo Liu, Miao Liu, Fuxiang Zhou, Guiling Li, Zhen Chen, et al. (+32)
205 [GO] Cancer Discovery 2020―Apr―24 COVID-19 Hits Cancer Research Funding
206 [GO] Cancer Discovery 2020―Apr―20 COVID-19 More Frequent, Severe in Cancer Patients
207 [GO] Clinical Cancer Research 2020―Apr―20 Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic Aaron C Tan, David M Ashley, Mustafa Khasraw
208 [GO] Cancer Discovery 2020―Apr―17 Harnessing CAR T Cell Insights to Develop Treatments for Hyperinflammatory Responses in COVID-19 patients Sangya Agarwal, Carl H. June
209 [GO] Cancer Discovery 2020―Apr―15 AACR Calls on Congress to Take Immediate Action Against COVID-19 and Protect Patients with Cancer During the Pandemic
210 [GO] Cancer Discovery 2020―Apr―10 Cancer Care Goes Virtual in Response to COVID-19
211 [GO] Cancer Discovery 2020―Apr―10 TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? Konrad H. Stopsack, Lorelei A. Mucci, Emmanuel S. Antonarakis, Peter S. Nelson, Philip W. Kantoff
212 [GO] Cancer Discovery 2020―Apr―01 Clinical Research Slows as COVID-19 Surges
213 [GO] Cancer Discovery 2020―Mar―31 Cancer Labs Pivot to Battle COVID-19
214 [GO] Cancer Discovery 2020―Mar―24 COVID-19 Challenges Basic Researchers
 [1] 

214 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.016 sec